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1.6	 0	 1	 1	 		 		
15-24	 18	
	
14.5	 1	 6	 11	 		 		
25-44	 46	
	
37.1	 7	 17	 22	 		 		
45-64	 30	
	
24.2	 4	 12	 14	 		 		
>=65	 28	
	








62.9	 11	 34	 33	 0.562	 		
Female	 46	
	








13.7	 1	 11	 5	 		 		
Outside	USA	 107	
	








9.7	 1	 8	 3	 		 		
Hispanic	or	Latino	 8	
	




20.2	 4	 8	 13	 		 		
Non-Hispanic	Asian,	Native	Hawaiian	
or	Other	Pacific	Islander	























30.7	 0	 10	 28	 		 		
Inconclusive	 10	
	
8.1	 0	 7	 3	 		 		
1+	 18	
	
14.5	 1	 8	 9	 		 		
2+	 12	
	
9.7	 1	 6	 5	 		 		
3+	 11	
	
8.9	 3	 6	 2	 		 		
4+	 35	
	








1.7	 0	 1	 1	 		 		
Abnormal,	Not	cavitary**	 87	
	
74.3	 11	 33	 43	 		 		
Abnormal,	Cavitary	 28	
	








17.7	 0	 6	 11	 		 		


















































































































































































































N	 %	 N	 %	 Mean	
Time-to-Detection	 		 		 		 		 		
0-7	days	 17	 18.1	 191	 24.2	 11.2	
8-14	days	 41	 43.6	 269	 34.1	 6.6	































N	 %	 N	 %	 Mean	 N	 %	 N	 %	 Mean	
Time-to-Detection	 		 		 		 		 		 		 		 		 		 		
0-7	days	 17	 18.1	 131	 25.6	 7.7	 3	 18.8	 60	 21.6	 20.0	
8-14	days	 41	 43.6	 223	 43.6	 5.4	 5	 31.3	 46	 16.6	 9.2	














































1.1	 0	 1	 0	 		 		
15-24	 9	
	
9.8	 1	 3	 5	 		 		
25-44	 40	
	
43.5	 7	 17	 16	 		 		
45-64	 22	
	
23.9	 4	 9	 9	 		 		
>=65	 20	
	
21.7	 5	 11	 4	 		 		
Sex	 	 	 	 	 	 	 	
Male	 59	
	
64.1	 11	 29	 19	 0.410	 		
Female	 33	
	








9.8	 1	 7	 1	 		 		
Outside	USA	 83	
	








7.6	 1	 5	 1	 		 		
Hispanic	or	Latino	 7	
	
7.6	 2	 3	 2	 		 		
Non-Hispanic	Black	or	African	American	 18	
	
19.6	 4	 6	 8	 		 		
Non-Hispanic	Asian,	Native	Hawaiian	or	
Other	Pacific	Islander	





















17.4	 0	 4	 12	 		 		
Inconclusive	 8	
	
8.7	 0	 6	 2	 		 		
1+	 14	
	
15.2	 1	 7	 6	 		 		
2+	 12	
	
13.0	 1	 6	 5	 		 		
3+	 10	
	
10.9	 3	 6	 1	 		 		
4+	 32	
	








2.3	 0	 1	 1	 		 		
Abnormal,	Not	cavitary**	 60	
	
69.0	 11	 25	 24	 		 		
Abnormal,	Cavitary	 25	
	








14.9	 0	 6	 5	 		 		
Positive	 63	
	

























N	 %	 N	 Row	%	 Lower	 Upper	





0-14	 137	 17.3	 29	 21.2	 		 Reference	
15-24	 200	 25.3	 32	 16.0	 		 0.71	 0.41	 1.24	
25-44	 200	 25.3	 77	 38.5	 		 2.33	 1.42	 3.84	
45-64	 138	 17.5	 54	 39.1	 		 2.39	 1.40	 4.08	
>=65	 85	 10.8	 29	 34.1	 		 1.93	 1.05	 3.54	





Male	 365	 46.6	 113	 31.0	 		 1.26	 0.92 1.72	
Female	 419	 53.4	 110	 26.3	 		 Reference	





Non-Hispanic	White	 149	 21.2	 14	 9.4	 		 Reference	
Hispanic	or	Latino	White	 58	 8.2	 9	 15.5	 		 1.77	 0.72	 4.35	
Non-Hispanic	Black	or	African	
American	 79	 11.2	 27	 35.2	 	 5.01	 2.44	 10.29	
Non-Hispanic	Asian,	Hawaiian	or	
Other	Pacific	Islander	 396	 56.3	 158	 39.9	 	 6.40	 3.56	 11.50	
Other*	 22	 3.1	 6	 27.3	 		 3.62	 1.22	 10.73	





USA	 334	 42.3	 31	 9.28	 		 Reference	
Outside	USA	 393	 49.8	 184	 46.82	 		 8.61	 5.66	 13.09	
Unknown	 63	 8.0	 10	 15.87	 		 1.84	 0.85	 3.98	





Other	 57	 7.2	 3	 5.3	 		 0.10	 0.03 0.31	
Private	Residence	 512	 64.8	 187	 36.5	 		 Reference	
School	 150	 19.0	 14	 9.3	 		 0.18	 0.10	 0.32	
Shelter/Single	Residence	Occupancy	 8	 1.0	 1	 12.5	 		 0.25	 0.03	 2.03	
Work	 63	 8.0	 20	 31.8	 		 0.81	 0.46	 1.42	





Household	Contact	 512	 64.8	 187	 36.5	 		 3.63	 2.47 5.35	
Non-Household	Contact	 278	 35.2	 38	 13.7	 		 Reference	
































All	Cases	 187	 512	 36.5	 		 		
Time-To-Detection	 		 		 		 		 		
0-7	days	 60	 131	 45.8	 1.392	 0.025	
8-14	days	 75	 223	 33.6	 1.022	 0.883	
15+	days	 52	 158	 32.9	 Reference	
Smear	 		 		 		 		 		
Negative/Inconclusive	 32	 108	 29.6	 Reference	
1+/2+	 42	 127	 33.1	 1.116	 0.572	
3+/4+	 113	 277	 40.8	 1.377	 0.043	
Smear	 		 		 		 		 		
Negative	 32	 108	 29.6	 Reference	
Positive	 155	 404	 38.4	 1.295	 	0.028	
Chest	radiographic	grade	(N=487)	 		 		 		 		 		
Normal	 1	 3	 33.3	 Reference	
Abnormal,	not	cavitary	 122	 339	 36.0	 1.080	 	0.924	
Abnormal,	cavitary	 63	 145	 43.4	 1.303	 	0.727	
NAAT	(N=411)	 		 		 		 		 		
Negative	 15	 64	 23.4	 Reference	















































0-7	days	 1.392	 0.087	 1.630	 0.023	
8-14	days	 1.022	 0.906	 1.503	 0.043	
15+	days	 Reference	 Reference	





1+/2+	 1.116	 0.646	 0.655	 0.120	
3+/4+	 1.377	 0.118	 1.088	 0.714	





Abnormal,	not	cavitary	 1.080	 0.937	 0.979	 0.987	
Abnormal,	cavitary	 1.303	 0.786	 0.745	 0.815	





Positive	 1.586	 0.103	 1.149	 0.699	
MODEL	2.	BIVARIATE	MODELS	 		 		 		 		




0-7	days	 1.242	 0.341	 1.440	 0.157	






1+/2+	 1.103	 0.691	 0.664	 0.128	
3+/4+	 1.242	 0.354	 0.924	 0.757	




0-7	days	 1.359	 0.206	 1.781	 0.030	






Positive	 1.453	 0.205	 1.225	 0.576	




0-7	days	 1.344	 0.117	 1.590	 0.028	






Abnormal,	not	cavitary	 0.993	 0.994	 0.845	 0.892	
Abnormal,	cavitary	 1.159	 0.881	 0.700	 0.774	
MODEL	3.	TRIVARIATE	MODELS	 	Household	Transmission*	 	All	Transmission**	




0-7	days	 1.323	 0.210	 1.538	 0.094	






1+/2+	 1.077	 0.756	 0.671	 0.146	





Abnormal,	not	cavitary	 0.950	 0.959	 1.041	 0.981	
Abnormal,	cavitary	 1.106	 0.921	 0.905	 0.936	




0-7	days	 1.386	 0.240	 1.495	 0.199	






1+/2+	 0.908	 0.741	 0.588	 0.136	





Positive	 1.496	 0.218	 1.235	 0.603	




0-7	days	 1.357	 0.188	 1.759	 0.032	











Abnormal,	not	cavitary	 0.749	 0.780	 0.630	 0.729	
Abnormal,	cavitary	 0.827	 0.856	 0.563	 0.669	
MODEL	4.	QUADRIVARIATE	MODELS	 		 		 		 		




0-7	days	 1.543	 0.108	 1.667	 0.105	






1+/2+	 0.951	 0.859	 0.588	 0.128	





Abnormal,	not	cavitary	 0.757	 0.792	 0.869	 0.915	





Positive	 1.538	 0.186	 1.242	 0.604	
*Cases	(N=92)	with	Transmission	Modeled	as	LTBI	among	Household	Contacts	Only	
**Cases	(N=94)	with	Transmission	Modeled	as	LTBI	among	All	Contacts	
Discussion	
Time	to	Detection	as	a	Predictor	of	Transmission	
The	primary	analyses	of	this	study	focused	on	risk	of	probable	transmission	to	household	
contacts	and	showed	that	in	this	group,	short	TTD	was	associated	with	a	greater	proportion	of	LTBI-
positive	results	compared	to	medium	and	long	TTD,	and	this	relationship	was	statistically	significant.	Yet	
the	proportion	of	LTBI	identified	by	short	TTD	was	only	5	percentage	points	greater	than	that	identified	
by	3+/4+	smears.	In	addition,	3+/4+	smears	identified	113	infections,	53	more	than	short	TTD,	including	
95%	of	the	cases	identified	by	short	TTD.		
Though	short	TTD	was	not	significantly	associated	with	transmission	in	univariate	or	multivariate	
analyses,	the	univariate	point	estimate	was	the	same	as	that	seen	in	the	LTBI	proportion	analysis	and	
thus	implicates	a	lack	of	power	to	detect	statistical	significance.	The	analyses	also	show	that	highest	
smear	grade—the	current	standard	metric	for	infectivity—also	performed	poorly	at	predicting	
household	transmission.	NAAT	and	chest	radiographic	grade	also	demonstrated	insignificant	
relationships,	however,	they	also	suffered	from	smaller	sample	sizes.	
Unexpectedly,	the	“All	Transmission”	cohort,	which	included	non-household	contacts,	did	
demonstrate	significant	predictors	of	transmission	in	several	models	including	the	TTD	univariate	model	
and	the	quadrivariate	model.	Across	all	contacts,	cases	with	short	and	medium	TTD	were	associated	
with	a	63.0%	and	50.3%	greater	transmission	rate	as	compared	to	cases	with	long	TTD,	not	adjusting	for	
other	diagnostic	tests.		
In	the	quadrivariate	model,	only	medium	TTD	remained	significantly	associated	with	
transmission.	In	comparison	to	long	TTD,	medium	TTD	was	associated	with	70.1%	greater	transmission	
rate	than	long	TTD,	after	adjusting	for	highest	smear,	chest	radiographic	grade,	and	NAAT,	and	
represented	a	higher	relative	rate	of	transmission	than	short	TTD.		
The	consistently	insignificant	results	in	the	household	transmission	models	are	likely	due	to	the	
high	background	rates	of	infection.	Among	household	contacts,	33%	were	associated	with	cases	with	
long	TTD	and	30%	were	linked	to	cases	with	negative	smears.	Household	contacts	were	more	likely	to	be	
foreign-born	(59.2%)	and	foreign-born	individuals	in	the	sample	were	more	likely	to	be	infected	than	US-
born	contacts.	In	the	literature,	foreign-born	contacts	are	more	likely	to	be	infected	prior	to	immigrating	
to	the	United	States37-39.	Because	there	is	no	way	to	distinguish	between	newly	or	previously	acquired	
LTBI,	infections	from	previous	exposures	cannot	be	excluded.	Thus,	a	high	background	rate	of	infection	
in	household	contacts	likely	contributes	to	the	high	proportion	of	LTBI	seen	in	the	contacts	of	cases	with	
long	TTD	(32.9%),	and	it	becomes	harder	to	find	a	statistically	significant	difference	in	infection	rates.		
Non-household	contacts,	by	contrast,	yielded	a	greater	proportion	of	US-born	individuals.	The	
proportion	of	foreign-born	contacts	in	the	“All	Contacts”	transmission	group	was	49.8%--almost	10	
percentage	points	less	than	household	contacts.	US-born	contacts	are	less	likely	to	have	LTBI	thus	the	
background	rate	of	LTBI	decreases	and	it	becomes	easier	statistically	to	find	a	difference	between	TTD	
strata.	However	the	non-household	contact	group	has	limitations	of	its	own	and	therefore	was	not	used	
for	primary	analyses.	Non-household	contacts	are	less	likely	to	have	as	high	an	exposure	to	the	case	as	
household	contacts	and	therefore	are	less	likely	to	be	a	true	transmission	event	from	the	index	case.	
Across	all	contacts,	household	contacts	had	greater	odds	of	infection	than	non-household	contacts.	
However	this	is	not	necessarily	always	the	case.	Some	individuals	may	spend	more	time	outside	the	
home	and,	for	example,	at	the	workplace	with	coworkers.	This	level	of	detail	is	not	contained	in	the	
contact	data.	
Additionally,	the	sample	of	non-household	contacts	is	heavily	affected	by	large	contact	
investigations.	Among	non-household	contacts,	the	largest	group	of	contacts	associated	with	a	single	
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case	was	a	school-based	investigation	in	which	95	contacts	were	screened,	which	produced	8	(8.4%)	
LTBI-positive	contacts.	These	large-scale	investigations	skew	results.	Though	cases	with	short	TTD	
tended	to	have	more	contacts	per	case	including	household	contacts	per	case,	on	average	there	were	
more	non-household	contacts	per	case	for	the	long	TTD	group.		
Because	we	predicted	there	to	be	lower	levels	of	exposure	among	non-household	contacts,	we	
expected	the	household	contact	transmission	models	to	produce	more	significant	results.	Overall,	the	
transmission	rate	among	household	contacts	was	greater	than	the	rate	across	all	contacts.	However	it	
appears	that	the	background	rate	of	infection	greatly	impacted	the	power	needed	to	find	statistical	
significance.	
Representativeness	of	the	Sample	
The	case	sample	appeared	to	be	demographically	representative	of	TB	nationally.	Overall,	62.9%	
of	the	group	was	male,	in	keeping	with	nationwide	findings	that	men	are	around	1.5	to	2	times	more	
likely	to	have	TB	than	women2.	A	large	proportion	of	the	sample	was	foreign-born	(86.3%),	with	the	
predominant	ethnic	group	being	non-Hispanic	Asian	(62.1%).	Nationwide	averages	show	that	66%	of	
reported	TB	cases	occurred	among	foreign-born	persons	and	that	Asian,	Native	Hawaiian	and	Pacific	
Islander	ethnic	groups	disproportionately	have	the	greatest	rates	of	TB2.	Seattle	is	an	international	hub	
for	immigration,	specifically	from	East	African	and	East	Asian	countries.	Thus	there	is	a	greater	
proportion	of	foreign-born	cases	in	the	county	than	across	the	United	States40.	
	The	household	transmission	case	cohort	(N=92)	differed	significantly	from	298	excluded	
pulmonary	TB	cases	by	highest	smear	grade,	culture	status,	NAAT,	anti-TB	treatment	prior	to	specimen	
collection,	extrapulmonary	TB	disease,	and	HIV	status.	Culture	status	and	anti-TB	treatment	were	part	of	
the	inclusion/exclusion	criteria	and	thus	the	difference	was	by	design.	The	household	transmission	case	
cohort	was	more	likely	to	have	higher	smear	grades	and	positive	NAAT	than	the	excluded	cases,	and	was	
less	likely	to	have	extrapulmonary	TB	disease	and	HIV.	
Limitations	
There	were	profound	limitations	unique	to	this	study	as	well	as	limitations	that	are	common	to	
the	field	of	observational	TB	research.	Specific	to	this	study,	there	are	challenges	to	the	underlying	data	
validity.	The	specimen	analyzed	for	TTD	is	the	first	culture-positive	specimen	analyzed	at	the	King	
County	Public	Health	Lab.	It	is	not	necessarily	the	diagnostic	specimen.	In	fact,	most	cases	are	diagnosed	
in	the	community	and	then	referred	to	the	county	TB	Control	Program.	The	main	consequence	of	this	
time	lag	between	diagnosis	and	analysis	is	that	many	of	the	cases	began	their	TB	treatment,	which	has	
been	shown	to	impact	culture	growth35,36.	We	buffered	against	this	impact	by	excluding	cases	that	had	
begun	treatment	prior	to	the	date	of	collection	of	the	TTD	specimen	(N=139;	35.6%)	resulting	in	124	
cases.	It	was	important	for	the	study	to	specifically	use	the	King	County	Lab	results	because	it	has	
consistent	record-keeping	of	dates	tested	versus	dates	reported	which	allowed	for	a	systematic	and	
accurate	calculation	of	TTD.	Inter-laboratory	variability	could	lead	to	measurement	error	in	the	predictor	
variable.	There	were	33	cases	with	no	King	County	Lab	(8.5%).	By	employing	strict	measures	to	improve	
data	quality,	sample	size	was	reduced,	and	consequently	statistical	power.	
Measurement	of	TTD	posed	other	challenges,	as	well.	Culture	samples	are	supposed	to	only	be	
cultured	for	56	days,	after	which	they	are	determined	culture-negative.	Yet	one	case	in	the	TTD	analysis	
cohort	(N=124)	had	a	TTD	of	63	days.	Additionally,	the	fluorescence	that	indicates	growth	has	to	be	
recorded	by	a	lab	technician.	If	the	culture	specimen	reaches	critical	mass	for	the	MGIT	system	to	detect	
fluorescence	during	the	weekend,	the	date	tested	would	only	be	recorded	the	following	workday.	
Therefore	holidays	and	weekends	could	have	caused	non-differential	misclassification	of	TTD.	
Another	limitation	to	using	the	first	culture-positive	specimen	from	the	King	County	Lab	is	that	it	
is	not	necessarily	the	specimen	with	the	shortest	TTD.	There	could	have	been	other	samples	with	a	
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different	culture	growth	time.	However	the	first	culture-positive	specimen	is	what	is	practically	useful	to	
contact	investigations	thus	that	is	the	sample	we	used.		
NAAT	data	came	from	the	PHIMS	database	RVCT	records—the	standard	report	required	for	
every	diagnosed	TB	case—and	had	substantial	missingness.	Of	cases	included	for	TTD	analysis	and	
household	transmission	analysis,	22.6%	and	19.6%	did	not	have	NAAT	results,	respectively.		
	 Chest	radiographic	grade	categorization	may	have	driven	non-significant	associations.	In	this	
study,	the	variable	was	classified	into	three	categories	(normal;	abnormal,	non-cavitary;	and	abnormal,	
cavitary).	Other	studies	have	included	categorizations	that	distinguish	between	unilateral	and	bilateral	
cavitary	disease,	a	single	cavitation	and	multiple,	as	well	as	predominantly	alveolar	and	predominantly	
interstitial	infection15,22.	It	has	been	shown	that	multiple	cavitations	are	associated	with	a	shorter	TTD	
and	greater	burden	of	disease41.	Thus	a	3-tier	categorization	may	have	been	too	coarse.	However	a	
greater	number	of	categories	would	have	also	reduced	sample	sizes	and	thus	power.	
	 Transmission	analysis	introduces	an	additional	set	of	limitations.	The	primary	challenge	to	
determining	whether	transmission	occurred	is	discerning	whether	a	contact’s	LTBI	truly	came	from	the	
case	in	this	study.	There	is	no	way	to	genotype	LTBI	thus	transmission	from	a	given	source	case	cannot	
be	genotypically	confirmed.	Additionally,	LTBI	is	common	worldwide.	The	WHO	estimates	that	more	
than	2	billion	people	--or	a	quarter	of	the	global	population--have	LTBI42.	Foreign-born	contacts	come	
from	a	variety	of	high-TB	prevalence	countries	thus	it	is	likely	that	exposure	occurred	before	
immigrating.		
	 Foreign-born	contacts	are	also	more	likely	to	have	received	the	BCG	vaccine,	which	can	lead	to	
an	unreliable	TST	result.	BCG	vaccine	has	been	shown	to	variably	interfere	with	TST	reactivity43.	Thus	it	
becomes	additionally	challenging	to	determine	whether	or	not	the	TST	results	are	a	product	of	LTBI	or	
the	vaccine.	Older	contacts	are	also	more	likely	to	be	LTBI-positive	from	a	previous	exposure2.	In	this	
study,	contact	age	was	significantly	associated	with	LTBI.	It	is	also	difficult	to	account	for	contact	
susceptibility.	HIV	infection	data	among	contacts	is	unreliable	as	well	as	documentation	of	other	risk	
factors.	
	 Finally,	it	is	challenging	to	appropriately	account	for	opportunities	for	transmission.	In	general,	
household	contacts	are	thought	to	have	greater	exposure	to	the	case,	than	non-household	contacts.	
However	it	is	not	always	the	case.	Overall,	it	is	difficult	to	account	for	the	length	of	exposure,	and	this	
level	of	detail	is	not	contained	in	the	contact	data.	
	 These	contact	characteristics,	which	speak	to	contact	susceptibility,	likely	confounded	the	
results	and	due	to	the	modeling	technique	could	not	be	appropriately	adjusted	for.	
Future	Studies	
Those	conducting	future	analyses	may	want	to	refine	the	contact	group	and	remove	foreign-
born	contact	TST	results.	Considering	a	large	proportion	of	foreign-born	individuals	are	BCG-vaccinated,	
QFT	is	be	a	more	reliable	measure	of	infection.	Another	possibility	is	to	limit	the	contact	cohort	to	
individuals	who	have	a	record	of	a	negative	TST	and	then	convert	to	a	positive	result.	These	would	
represent	the	most	accurate	true	transmission	events	and	thus	could	provide	the	most	accurate	
measure	of	transmission.		
Additionally,	studies	may	want	to	consider	modeling	techniques	other	than	Poisson	regression.	
Though	Poisson	was	able	to	take	into	account	the	number	of	LTBI-positive	contacts	within	the	context	of	
the	total	number	of	contacts,	it	could	not	adjust	for	contact	susceptibility.	
Finally,	future	surveillance	efforts	must	make	a	better	effort	to	collect	complete	data	on	
contacts	in	contact	investigations.	Only	through	thorough	cleaning	was	the	dataset	usable.		
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Conclusions	
While	TTD	appears	to	have	some	ability	to	discriminate	between	more	and	less	infectious	TB	
cases,	we	were	unable	to	show	it	added	to	current	infectivity	measures,	especially	to	the	use	of	3+/4+	
smear	grade	positivity.	Sample	size	also	contributed	greatly	to	the	lack	of	statistical	power.	There	are	
substantial	challenges	to	conducting	observational	studies	of	TB	transmission,	particularly	where	there	
are	high	background	rates	of	LTBI.	As	one	clinician	said,	“Smear	[the	current	gold	standard	of	infectivity]	
being	non-significant	validates	the	difficulty	of	telling	what	actually	happens	with	transmission	in	
contact	investigations.”	Future	studies	to	determine	the	usefulness	of	diagnostic	tests	to	predict	
transmission	should	take	place	in	previously	TB-naïve	households.	
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